Cavit Sciences

Cavit Sciences was a biotechnology company primarily engaged in the research and development of treatments for viral infections and various forms of cancer. The company's lead research focused on developing topical therapies for Human Papillomavirus (HPV) and cervical dysplasia. Additionally, Cavit Sciences explored treatments for skin cancer and other oncological conditions. While formerly active in the public markets, the company has since become inactive, with its primary development programs stalled in the early stages of the clinical pipeline. Its business model relied on the licensing and development of proprietary medicinal technologies.